Literature DB >> 22138735

Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of multiple myeloma: initial clinical efficiency results.

Miyuki Takasu1, Chihiro Tani, Yasuko Sakoda, Miho Ishikawa, Keizo Tanitame, Shuji Date, Yuji Akiyama, Akira Sakai, Hideki Asaoku, Toshio Kajima, Kazuo Awai.   

Abstract

OBJECTIVES: To evaluate the effectiveness of the iterative decomposition of water and fat with echo asymmetric and least-squares estimation (IDEAL) MRI to quantify tumour infiltration into the lumbar vertebrae in myeloma patients without visible focal lesions.
METHODS: The lumbar spine was examined with 3 T MRI in 24 patients with multiple myeloma and in 26 controls. The fat-signal fraction was calculated as the mean value from three vertebral bodies. A post hoc test was used to compare the fat-signal fraction in controls and patients with monoclonal gammopathy of undetermined significance (MGUS), asymptomatic myeloma or symptomatic myeloma. Differences were considered significant at P < 0.05. The fat-signal fraction and β(2)-microglobulin-to-albumin ratio were entered into the discriminant analysis.
RESULTS: Fat-signal fractions were significantly lower in patients with symptomatic myelomas (43.9 ±19.7%, P < 0.01) than in the other three groups. Discriminant analysis showed that 22 of the 24 patients (92%) were correctly classified into symptomatic or non-symptomatic myeloma groups.
CONCLUSIONS: Fat quantification using the IDEAL sequence in MRI was significantly different when comparing patients with symptomatic myeloma and those with asymptomatic myeloma. The fat-signal fraction and β(2)-microglobulin-to-albumin ratio facilitated discrimination of symptomatic myeloma from non-symptomatic myeloma in patients without focal bone lesions. KEY POINTS: • A new magnetic resonance technique (IDEAL) offers new insights in multiple myeloma. • Fat-signal fractions were lower in patients with symptomatic myelomas than in those with asymptomatic myelomas. • The β2-microglobulin-to-albumin ratio also aided discrimination of symptomatic myeloma. • The fat-signal fraction may provide information about the myeloma cell mass.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138735     DOI: 10.1007/s00330-011-2351-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  Guidelines on the diagnosis and management of multiple myeloma 2005.

Authors:  Alastair Smith; Finn Wisloff; Diana Samson
Journal:  Br J Haematol       Date:  2006-02       Impact factor: 6.998

2.  Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging.

Authors:  Scott B Reeder; Angel R Pineda; Zhifei Wen; Ann Shimakawa; Huanzhou Yu; Jean H Brittain; Garry E Gold; Christopher H Beaulieu; Norbert J Pelc
Journal:  Magn Reson Med       Date:  2005-09       Impact factor: 4.668

3.  IDEAL imaging of the musculoskeletal system: robust water fat separation for uniform fat suppression, marrow evaluation, and cartilage imaging.

Authors:  Clint M Gerdes; Richard Kijowski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2007-11       Impact factor: 3.959

4.  Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.

Authors:  A Stäbler; A Baur; R Bartl; R Munker; R Lamerz; M F Reiser
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

5.  Modic vertebral body changes: the natural history as assessed by consecutive magnetic resonance imaging.

Authors:  Michael J Hutton; Jens H Bayer; John M Powell
Journal:  Spine (Phila Pa 1976)       Date:  2011-12-15       Impact factor: 3.468

6.  Whole-body (18)F-FDG PET identifies high-risk myeloma.

Authors:  Brian G M Durie; Alan D Waxman; Allesandro D'Agnolo; Cindy M Williams
Journal:  J Nucl Med       Date:  2002-11       Impact factor: 10.057

7.  Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

Authors:  Meletios Dimopoulos; Robert Kyle; Jean-Paul Fermand; S Vincent Rajkumar; Jesus San Miguel; Asher Chanan-Khan; Heinz Ludwig; Douglas Joshua; Jayesh Mehta; Morie Gertz; Hervé Avet-Loiseau; Meral Beksaç; Kenneth C Anderson; Philippe Moreau; Seema Singhal; Hartmut Goldschmidt; Mario Boccadoro; Shaji Kumar; Sergio Giralt; Nikhil C Munshi; Sundar Jagannath
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

8.  Water-fat separation with IDEAL gradient-echo imaging.

Authors:  Scott B Reeder; Charles A McKenzie; Angel R Pineda; Huanzhou Yu; Ann Shimakawa; Anja C Brau; Brian A Hargreaves; Garry E Gold; Jean H Brittain
Journal:  J Magn Reson Imaging       Date:  2007-03       Impact factor: 4.813

9.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

10.  Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden.

Authors:  M Hjorth; L Hellquist; E Holmberg; B Magnusson; S Rödjer; J Westin
Journal:  Eur J Haematol       Date:  1993-02       Impact factor: 2.997

View more
  14 in total

1.  Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Peter Johannes Wagenhäuser; Michael Meier-Schroers; Daniel Lloyd Kuetting; Andreas Feißt; Jürgen Gieseke; Leonard Christopher Schmeel; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

2.  Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology.

Authors:  Timothy Jp Bray; Manil D Chouhan; Shonit Punwani; Alan Bainbridge; Margaret A Hall-Craggs
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

3.  Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy.

Authors:  Y Kaichi; K Tanitame; H Itakura; H Ohno; M Yoneda; Y Takahashi; Y Akiyama; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

4.  Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) magnetic resonance imaging as a biomarker for symptomatic multiple myeloma.

Authors:  Miyuki Takasu; Yoko Kaichi; Chihiro Tani; Shuji Date; Yuji Akiyama; Yoshiaki Kuroda; Akira Sakai; Kazuo Awai
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

5.  Magnetic resonance evaluation of multiple myeloma at 3.0 Tesla: how do bone marrow plasma cell percentage and selection of protocols affect lesion conspicuity?

Authors:  Miyuki Takasu; Takayuki Tamura; Yoko Kaichi; Keizo Tanitame; Yuji Akiyama; Shuji Date; Akira Sakai; Yoshiaki Kuroda; Kazuo Awai
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.

Authors:  Arash Latifoltojar; Margaret Hall-Craggs; Neil Rabin; Rakesh Popat; Alan Bainbridge; Nikolaos Dikaios; Magdalena Sokolska; Ali Rismani; Shirley D'Sa; Shonit Punwani; Kwee Yong
Journal:  Br J Haematol       Date:  2016-10-21       Impact factor: 6.998

7.  Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.

Authors:  Arash Latifoltojar; Margaret Hall-Craggs; Alan Bainbridge; Neil Rabin; Rakesh Popat; Ali Rismani; Shirley D'Sa; Nikolaos Dikaios; Magdalena Sokolska; Michela Antonelli; Sebastien Ourselin; Kwee Yong; Stuart A Taylor; Steve Halligan; Shonit Punwani
Journal:  Eur Radiol       Date:  2017-06-27       Impact factor: 5.315

8.  Thyroid-associated Orbitopathy: Quantitative Evaluation of the Orbital Fat Volume and Edema Using IDEAL-FSE.

Authors:  Yoko Kaichi; Keizo Tanitame; Hiroaki Terada; Hideki Itakura; Haruya Ohno; Masayasu Yoneda; Yuji Takahashi; Yuji Akiyama; Kazuo Awai
Journal:  Eur J Radiol Open       Date:  2019-05-18

9.  Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.

Authors:  Mengtian Sun; Jingliang Cheng; Cuiping Ren; Yong Zhang; Yinhua Li; Ying Li; Suping Zhang
Journal:  Quant Imaging Med Surg       Date:  2021-08

10.  Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study.

Authors:  Timothy J P Bray; Saurabh Singh; Arash Latifoltojar; Kannan Rajesparan; Farzana Rahman; Priya Narayanan; Sahar Naaseri; Andre Lopes; Alan Bainbridge; Shonit Punwani; Margaret A Hall-Craggs
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.